Sum­mit Ther­a­peu­tics touts a rare tri­umph over Keytru­da in lung can­cer from a Chi­na-on­ly Phase 3 study

Hours be­fore Amer­i­ca’s biggest can­cer con­fer­ence starts in Chica­go, a small biotech may have stolen the show, tout­ing late-stage re­sults in a Thurs­day af­ter­noon press …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER